Aminergic and Peptidergic Receptors. Satellite Symposium of the 3rd Congress of the Hungarian Pharmacological Society, Szeged, Hungary, 1979

Content: 
ADVANCES IN PHARMACOLOGICAL RESEARCH AND PRACTICE, Page ii
Front Matter, Page iii
Copyright, Page iv
PREFACE, Page xi, L. Szekeres
PHARMACOLOGICAL CONTROL OF THE ADVERSE EFFECTS OF CORONARY INSUFFICIENCY, Pages 3-4, L. Szekeres
METABOLIC CHANGES DUE TO MYOCARDIAL ISCHEMIA, Pages 5-9, M. Siess
EFFECTS OF ISCHEMIC METABOLITES ON THE MITOCHONDRIAL MEMBRANE, Pages 11-16, P.L Vághy, P. Bor, J. Pataricza, L. Szekeres
ANTIANGINAL AND ANTIARRHYTHMIC AGENTS AND CELLULAR COMPONENTS, Pages 17-19, A. Ziegelhöffer
EFFECT OF MYOCARDIAL ISCHAEMIA ON THE BASIC ELECTRICAL PHENOMENA IN THE HEART CELL, Pages 21-30, J.Gy. Papp, M. Németh, L. Szekeres
ARRHYTHMOGENIC ACTION OF LOCAL MYOCARDIAL ISCHEMIA, Pages 31-37, L. Szekeres, Matild Blazsovszky, J. Hernandez, éva Udvary
SIGNIFICANCE OF THE AUTONOMIC NERVOUS SYSTEM IN THE APPEARANCE OF ARRHYTHMIAS DUE TO CORONARY OCCLUSION, Pages 39-42, T. Pérez-Medina, Mária Garamszegi, éva Udvary, L. Szekeres
INFLUENCE OF HYPOTHYROIDISM ON CARDIAC ARRHYTHMIAS INDUCED BY CORONARY OCCLUSION, Pages 43-47, Erzsébet Boros, Matild Blazsovszky, J. Gy. Papp, L. Szekeres
INFLUENCE OF THYROTOXICOSIS ON DISORDERS OF CARDIAC RHYTHM APPEARING IN CORONARY INSUFFICIENCY, Pages 49-53, Matild Blazsovszky, Erzsébet Boros, J. Gy. Papp, L. Szekeres
ACUTE EFFECT OF ANTIARRHYTHMIC DRUGS IN HEART RHYTHM DISTURBANCES DUE TO MYOCARDIAL ISCHEMIA, Pages 55-58, éva Csordás Nagy, éva Udvary, L. Szekeres
EFFECT OF PROLONGED TREATMENT WITH ANTIARRHYTHMIC AND ANTIANGINAL DRUGS ON THE INCIDENCE OF VENTRICULAR FIBRILLATION AND DEATH IN THE ACUTE PHASE OF MYOCARDIAL INFARCTION IN AWAKE RATS, Pages 59-62, I. Leprán, L. Szekeres
EFFECT OF PENTOBARBITONE ANESTHESIA, AGE AND SEX IN THE ACUTE PHASE OF MYOCARDIAL INFARCTION IN RATS, Pages 63-66, W. Siegmund, I. Leprán, L. Szekeres
IMPORTANCE OF METABOLIC CHANGES IN THE ANTIANGINAL EFFECT OF DRUGS AT THE SUBCELLULAR LEVEL, Pages 67-70, P. Bor, P.L Vághy, J. Pataricza, L. Szekeres
SIGNIFICANCE OF METABOLIC ALTERATIONS IN THE EFFECT OF ANTIANGINAL DRUGS AT THE CELLULAR LEVEL, Pages 71-73, I. Takáts, Mária Garamszegi, L. Szekeres
IMPORTANCE OF METABOLIC CHANGES IN THE ANTIANGINAL ACTION OF DRUGS AT THE ORGAN LEVEL, Pages 75-79, Vera Csik, L. Szekeres, éva Udvary
ROLE OF HEMODYNAMICS IN THE ANTIANGINAL ACTION OF DRUGS, Pages 81-84, éva Udvary, Irén Krassói, L. Szekeres
EFFECT OF A DRUG COMBINATION IN THE EXPERIMENTAL MODEL OF ANGINA PECTORIS, Pages 85-88, Irén Krassói, L. Szekeres, éva Udvary
EFFECT OF DRUGS ON CEREBRAL CIRCULATION IN CHRONIC CEREBRAL ISCHEMIA, Pages 89-92, Emöke Nagy, L. Szekeres
ADRENERGIC MECHANISMS IN CORONARY VASCULAR CONTROL AND OXYGEN METABOLISM FOLLOWING BRIEF REGIONAL MYOCARDIAL ISCHEMIA, Pages 93-97, J. DŘímal, P. Gibala
CHANGES IN THE CONTRACTILITY AND CATECHOLAMINE-SENSITIVITY OP MYOCARDIUM IN ISOPROTERENOL-INDUCED CARDIAC HYPERTROPHY, Pages 101-104, J. Szegi, A.J Szentmiklósi, ágnes Cseppentö, Judith Szabó, Ildikó E. Takács
THE ROLE OP THYROID STATE IN THE INOTROPIC EFFECT OF ADENOSINE ON VENTRICULAR MYOCARDIUM, Pages 105-108, A.J Szentmiklósi, ágnes Cseppentö, Judith Szabó, Ildikó E. Takács, J. Szegi
ALTERATION OF CATECHOLAMINE-SENSITIVITY IN THYROXINE-INDUCED MYOCARDIAL HYPERTROPHY, Pages 109-112, ágnes Cseppentö, A.J Szentmiklósi, Judith Szabó, Ildikó E. Takács, J. Szegi
REGULATION OP β-ADRENERGIC RECEPTORS IN HEART MUSCLE SOME ASPECTS, Pages 113-124, Liane Will-Shahab
INVESTIGATION ON THE ALTERED PROPERTIES OP MYOSIN ASSOCIATED WITH CARDIAC HYPERTROPHY, Pages 125-128, á. Szöör, Judith Szabó, Klára Nosztray, Ildikó E. Takács, J. Szegi
BIOCHEMICAL PARAMETERS RELATED TO CARDIOMEGALY, Pages 129-132, Ildikó E. Takács, Judith Szabó, Klára Nosztray, J. Szegi
STUDIES ON THE MYOSIN ATPase ACTIVITY IN EXPERIMENTALLY-INDUCED CARDIAC HYPERTROPHY IN RATS, Pages 133-136, A. Szöör, Klára Nosztray, Judith Szabó, Ildikó E. Takács, J. Szegi
CARDIAC ARRHYTHMIAS INDUCED BY ELECTRICAL AND CHEMICAL STIMULATION OF SOME HYPOTHALAMIC NUCLEI IN THE RATS, Pages 137-141, B. Cuparencu, L. Safta, V.V. Papilian, Vl. SLandor, J. Horák
AN ANALYSIS OF ANTIHYPERTENSIVE DRUGS, Pages 145-161, F. Gross
PHARMACOLOGIC CONTROL OF HYPERTENSIVE EMERGENCIES, Pages 163-167, Jan Koch-Weser
SOME STUDIES ON THE CENTRAL ACTIONS OF BETA-ADRENOCEPTOR BLOCKING DRUGS IN MAN, Pages 169-172, Paul Turner
MODE OF ACTION OF CENTRALLY ACTING ANTIHYPERTENSIUE DRUGS, Pages 173-178, P.A. van Zwieten
THE INFLUENCE OF HYPOTENSIVE DRUGS ON ADAPTIVE HEMODYNAMIC REACTIONS, Pages 179-183, A.V. Valdman
THE CARDIOVASCULAR PATTERN OF CLONIDINE-LIKE ANTIHYPERTENSIVE SUBSTANCES AND THEIR MODE OF ACTION, Pages 185-189, W. Kobinger
INVOLVEMENT OF PRESYNAPTIC AND POSTSYNAPTIC α-ADRENOCEPTORS IN THE ACTION OF CLONIDINE-LIKE SUBSTANCES, Pages 191-195, L. Pichler
TACHYPHYLAXIS TO THE HYPOTENSIVE EFFECT OF CLONIDINE ON RATS, Pages 197-201, Katalin P. Gibiszer, J. Pórszász, Jr.
HYPOTENSIVE EFFECT OF CLONIDINE AND REGIONAL NORADRENALINE CONCENTRATION IN THE BRAIN OF NORMOTENSIVE AND HYPERTENSIVE RATS AFTER ACUTE AND CHRONIC TREATMENT, Pages 203-208, M. Filczewski, M. Szymańska-Kosmala, K. Oledzka, E. Bogucka
THE EFFECT OF INDOMETHACIN ON RENIN-ANGIOTENCIN-ALDOSTERONE SYSTEM IN ESSENTIAL HYPERTENSION, Pages 209-214, I. Tényi, M. Németh, J. Nemes
CROSS-OVER TRIAL FOR COMPARING ANTIHYPERTENSIVE EFFECTS OF PRAZOSIN AND HYDRALAZINE, Pages 215-220, M. Németh, I. Tényi, J. Nemes, T. Jávor
TAURINE AND HYPERTENSION, Pages 221-225, Matti K. Paasonen, Jaakko-Juhani Himberg, Olli Penttilä, Erkka Solatunturi, Pauli Ylitalo
PLANNING OP ANTIHYPERTENSIVE PYRIDAZINE COMPOUNDS, Pages 227-232, E. Kasztreiner, G. Szilágyi, Zs. Huszti, P. Mátyus, J. Kosáry, L. Tardos, E. Kósa, L. Jaszlits, Gy. Cseh
PHARMACOLOGY OP GYKI-11.679, A NEW ANTIHYPERTENSIVE DRUG, Pages 233-237, Edit Kósa, L. Jaszlits, L. Tardos
THE ANTIHYPERTENSIVE EFFECT OF MORPHOLINO-PYRIDAZINYL-HYDRAZINE AND ITS HYDRAZONE DERIVATIVE, Pages 239-243, L. Tardoa, E. Kósa, L. Jaszlits, I. Berzétei, A. Rónai
PHARMACOLOGICAL CONTROL OF DISSEMINATED INTRAVASCULAR COAGULATION (DIC), Pages 245-250, F. Markwardt
PHARMACOLOGY OF GYKI-41099 /CHLORPROPANOL, TOBANUM® A NEW POTENT BETA-ADRENERGIC ANTAGONIST, Pages 253-261, M.I.K. Fekete, J. Borvendég, Marianne Kürti
EFFECTS OF TQBANUM(GYKI 41099) ON CARDIAC TRANSMEMBRANE POTENTIALS, Pages 263-266, V. KECSKEMÉTI
HUMAN PHARMACOKINETIC STUDY ON TOBANUM®, Pages 267-272, I. Elekes, é. Tomori, M. Pátfalusi, T. Past
TOBANUM /GYKI-41099/ EFFECT ON INTRINSIC HEART RATE, Pages 273-276, éva Péterfai, B. Gachályi, A. Káldor
ANTIARRHYTHMIC PROPERTIES OF TOBANUM® A NEW BETA-BLOCKING AGENT, Pages 277-281, P. Solti, E. Czakó
THE HAEMODYNAMIC EFFECT OF THE BETA-BLOCKING AGENT GYKT-41099 /TOBANUM®/ ON ISCHEMIC CARDIAC PATIENTS, Pages 283-287, E. Berentey, F. Molnár, A. Böhm
TOBANUM /GYKI 41099/ IN HYPERTENSION - A MULTICENTRE CLINICAL TRIAL, Pages 289-294, E. Török, J. Borvendég, J. Eggenhofer, M. Csukás
THE EFFECT OF GYKI-41099 ON PLASMA RENIN ACTIVITY AND BLOOD PRESSURE OF ESSENTIAL HYPERTENSION, Pages 295-300, J. Némés, I. Tényi, M. Németh, T. Jávor
COMPARATIVE STUDY ON TOBANUM® /GYKI-41099/ AND PINDOLOL ON PATIENTS SUFFERING FROM MODERATE OR SEVERE HYPERTENSION, Pages 301-305, E. Iván, J. Eggenhofer, M. Csukás
EFFECT OF GYKI-41099, A NEW BETA-ADRENERGIC RECEPTOR BLOCKING AGENT, ON THE RESPONSES OF CAROTID SINUS BARORECEPTOR REFLEX IN MAN, Pages 307-313, L. Bódis, B. Radnai, I. Tényi
STUDIES ON A NEW β -RECEPTOR BLOCKING DRUG: TOBANUM® (1-/2,5-DICHLOROPHENOXY/-3-TERTIARY-BUTYLAMINOPROPANOL-2-HCl). EXPERIENCES IN CARDIOVASCULAR HYPERKINETIC SYNDROME AND ANGINA PECTORIS. EFFECT ON THE RESPIRATION, Pages 315-319, I. Szám, P. Büky, A. Gulyás, J. Fischer
PRINCIPLES OP CLINICAL TREATMENT WITH TOBANUM /GYKI 41099/ IN CARDIAC DYSRHYTHMIAS, Pages 321-324, M. Békés, J. Borbola, J. Hankóczy
COMPARATIVE STUDY OP THE BETA-ADRENERGIC BLOCKING AGENTS GYKI-41099 /TOBANUM/ AND PROPRANOLOL IN THYROTOXIC PATIENTS, Pages 325-330, J. Földes, J. Borvendég, A. Váradi, Ca Bános, J. Brüll
ON THE EFFECTS OF COMPOUND GYKI-32.594, A NEW POTENT SEROTONIN ANTAGONIST, Pages 333-340, J. Borsy, Erzsébet Magó-Karácsony, T. Balogh, Ildikó Király, Eleonora Szondy, Ilona Berzétei
EFFECTS OF DRUGS AFFECTING SEROTONERGIC SYSTEM ON ACTIVITY OF CENTRAL DOPAMINERGIC AND SEROTONERGIC SYSTEMS IN RATS, Pages 341-345, Anna Rokosz, Lucyna Antkiewicz-Michaluk, Jerzy Vetulani
DOSE-DEPENDENT OPPOSITE EFFECTS OF THE 5-HT RECEPTOR ANTAGONISTS ON THE 5-HT-INDUCED RESPONSES IN THE RAT, Pages 347-350, Z. Górka, E. Wojtasik, H. Kwiatek
EFFECTS OF SOME INDOLINES IN COMPARISON WITH SEROTONIN ON THE GUINEA-PIG ISOLATED ILEUM, Pages 351-356, M. Müller, W. Fischer
DETECTION OF 5-HYDROXYTRYPTAMINE RECEPTORS IN SOME VASCULAR SMOOTH MUSCLE PREPARATIONS, Pages 357-360, Anikó Kovács, L. Kerecsen
THE MODIFICATION OF THE PATHOLOGICAL CEREBRAL CIRCULATION ON THE EFFECT OF CAVINTON, Pages 363-367, F. Solti, M. Iskum, A. Váradi
THE EFFECT OF CAVINTON AND XAVIN ON THE REDOX CHANGES IN THE BRAIN OF STROKE PATIENTS, Pages 369-374, L. Molnár, B. Vámosi
CLINICAL STUDIES ON CAVINTON R, Pages 375-379, G.M. Rudenko
THE EFFECT OF CAVINTON® IN ISCHAEMIC DISTURBANCES OF THE CEREBRAL CIRCULATION, Pages 381-385, D. Hadjiev, St. Yancheva
TREATMENT OF ACUTE AND CHRONIC ISCHEMIC CEREBROVASCULAR DISEASE WITH CAVINTON, Pages 387-393, E. Csanda, P. Harcos, Zs Bácsy
EVALUATION OF CAVINTON EFFECTS IN PATIENTS WITH CEREBRAL VASCULAR LESIONS, Pages 395-399, P. Kalvach, V. Ságová, J. Bauer
THE VALUE OF CAVINTON THERAPY IN RETINAL AND CHOROIDAL DISORDERS, Pages 401-407, I. świetliczko, L. Zeydler-Grzedzielewska, K. Baszczyńska-Zielińska, W. Braciak
EFFECT OF ETHYL-APOVINCAMINATE ON THE COCHLEOVESTIBULAR SYSTEM - A COMPARATIVE INVESTIGATION, Pages 409-413, E. Nagymajtényi, O. Ribári, é. Szabados, E. Katona
CEREBRAL CIRCULATORY, ANTIHYPOXIC AND CITS ACTIVITY OP INDOLE DERIVATIVES, Pages 415-422, D. Groó, é. Pálosi, E. Kárpáti
NEW INDOLE DERIVATIVES INCREASE THE ABILITY OF THE BRAIN TO TOLERATE THE EFFECTS OF SERIAL ASPHYXIC HYPOXIA IN RAT, Pages 423-428, á. Sarkadi, S. Szabó, L. Szporny
BIOCHEMICAL EFFECTS OF SEMI-SYNTHETIC VINCAALKALOIDS ON THE CYCLIC AMP SYSTEM, Pages 429-433, E. Lapis, Z.M Balázs, B. Rosdy
A NEW CLASS OF 3′,5′-cAMP PHOSPHODIESTERASE INHIBITORS: APOVINCINE DERIVATIVES, Pages 435-439, Z.M Balázs, B. Rosdy, L. Szporny
SUBJECT INDEX, Pages 441-443